vs

Side-by-side financial comparison of MEDIFAST INC (MED) and National Bank Holdings Corp (NBHC). Click either name above to swap in a different company.

National Bank Holdings Corp is the larger business by last-quarter revenue ($126.8M vs $75.1M, roughly 1.7× MEDIFAST INC). Over the past eight quarters, National Bank Holdings Corp's revenue compounded faster (14.0% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Old National Bank is an American regional bank with nearly 200 retail branches operated by Old National Bancorp and based in Chicago and Evansville, Indiana. With assets at $48.5 billion and 250 banking centers, Old National Bancorp is the largest financial services bank holding company headquartered in Indiana and one of the top 30 banking companies in the U.S. Old National Bank has locations in Illinois, Indiana, Iowa, Kentucky, Michigan, Minnesota, Tennessee, and Wisconsin.

MED vs NBHC — Head-to-Head

Bigger by revenue
NBHC
NBHC
1.7× larger
NBHC
$126.8M
$75.1M
MED
Faster 2-yr revenue CAGR
NBHC
NBHC
Annualised
NBHC
14.0%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MED
MED
NBHC
NBHC
Revenue
$75.1M
$126.8M
Net Profit
$20.8M
Gross Margin
69.4%
Operating Margin
-10.4%
Net Margin
16.4%
Revenue YoY
-36.9%
Net Profit YoY
-14.2%
EPS (diluted)
$-1.64
$0.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
NBHC
NBHC
Q1 26
$126.8M
Q4 25
$75.1M
$100.6M
Q3 25
$89.4M
$108.9M
Q2 25
$105.6M
$104.5M
Q1 25
$115.7M
$102.1M
Q4 24
$119.0M
$101.3M
Q3 24
$140.2M
$106.0M
Q2 24
$168.6M
$97.6M
Net Profit
MED
MED
NBHC
NBHC
Q1 26
$20.8M
Q4 25
$16.0M
Q3 25
$-2.3M
$35.3M
Q2 25
$2.5M
$34.0M
Q1 25
$-772.0K
$24.2M
Q4 24
$28.2M
Q3 24
$1.1M
$33.1M
Q2 24
$-8.2M
$26.1M
Gross Margin
MED
MED
NBHC
NBHC
Q1 26
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Operating Margin
MED
MED
NBHC
NBHC
Q1 26
Q4 25
-10.4%
19.0%
Q3 25
-4.6%
39.6%
Q2 25
-1.0%
39.8%
Q1 25
-1.1%
29.2%
Q4 24
0.6%
34.3%
Q3 24
1.5%
37.6%
Q2 24
-4.7%
32.5%
Net Margin
MED
MED
NBHC
NBHC
Q1 26
16.4%
Q4 25
15.9%
Q3 25
-2.5%
32.4%
Q2 25
2.3%
32.6%
Q1 25
-0.7%
23.7%
Q4 24
27.8%
Q3 24
0.8%
31.2%
Q2 24
-4.8%
26.8%
EPS (diluted)
MED
MED
NBHC
NBHC
Q1 26
$0.46
Q4 25
$-1.64
$0.42
Q3 25
$-0.21
$0.92
Q2 25
$0.22
$0.88
Q1 25
$-0.07
$0.63
Q4 24
$0.08
$0.72
Q3 24
$0.10
$0.86
Q2 24
$-0.75
$0.68

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
NBHC
NBHC
Cash + ST InvestmentsLiquidity on hand
$167.3M
$472.8M
Total DebtLower is stronger
$202.1M
Stockholders' EquityBook value
$198.9M
$1.7B
Total Assets
$248.0M
$12.6B
Debt / EquityLower = less leverage
0.12×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
NBHC
NBHC
Q1 26
$472.8M
Q4 25
$167.3M
$417.1M
Q3 25
$173.5M
$555.6M
Q2 25
$162.7M
$296.5M
Q1 25
$164.6M
$246.3M
Q4 24
$162.3M
$127.8M
Q3 24
$170.0M
$180.8M
Q2 24
$163.5M
$145.0M
Total Debt
MED
MED
NBHC
NBHC
Q1 26
$202.1M
Q4 25
$54.5M
Q3 25
$54.7M
Q2 25
$54.4M
Q1 25
$54.6M
Q4 24
$54.5M
Q3 24
$54.4M
Q2 24
$54.4M
Stockholders' Equity
MED
MED
NBHC
NBHC
Q1 26
$1.7B
Q4 25
$198.9M
$1.4B
Q3 25
$214.7M
$1.4B
Q2 25
$216.0M
$1.4B
Q1 25
$211.0M
$1.3B
Q4 24
$210.1M
$1.3B
Q3 24
$207.3M
$1.3B
Q2 24
$205.3M
$1.2B
Total Assets
MED
MED
NBHC
NBHC
Q1 26
$12.6B
Q4 25
$248.0M
$9.9B
Q3 25
$268.2M
$10.2B
Q2 25
$269.3M
$10.0B
Q1 25
$280.0M
$10.1B
Q4 24
$284.2M
$9.8B
Q3 24
$291.2M
$10.0B
Q2 24
$293.5M
$10.0B
Debt / Equity
MED
MED
NBHC
NBHC
Q1 26
0.12×
Q4 25
0.04×
Q3 25
0.04×
Q2 25
0.04×
Q1 25
0.04×
Q4 24
0.04×
Q3 24
0.04×
Q2 24
0.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
NBHC
NBHC
Operating Cash FlowLast quarter
$-5.3M
Free Cash FlowOCF − Capex
$-6.6M
FCF MarginFCF / Revenue
-8.8%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
NBHC
NBHC
Q1 26
Q4 25
$-5.3M
$162.4M
Q3 25
$12.1M
$52.4M
Q2 25
$-3.4M
$32.3M
Q1 25
$3.4M
$39.6M
Q4 24
$-4.9M
$155.3M
Q3 24
$9.1M
$47.0M
Q2 24
$13.1M
$31.9M
Free Cash Flow
MED
MED
NBHC
NBHC
Q1 26
Q4 25
$-6.6M
Q3 25
$10.8M
Q2 25
$-4.8M
Q1 25
$1.9M
Q4 24
$-7.2M
Q3 24
$7.7M
Q2 24
$11.1M
FCF Margin
MED
MED
NBHC
NBHC
Q1 26
Q4 25
-8.8%
Q3 25
12.0%
Q2 25
-4.5%
Q1 25
1.6%
Q4 24
-6.1%
Q3 24
5.5%
Q2 24
6.6%
Capex Intensity
MED
MED
NBHC
NBHC
Q1 26
Q4 25
1.8%
Q3 25
1.5%
Q2 25
1.3%
Q1 25
1.3%
Q4 24
1.9%
Q3 24
1.0%
Q2 24
1.1%
Cash Conversion
MED
MED
NBHC
NBHC
Q1 26
Q4 25
10.13×
Q3 25
1.48×
Q2 25
-1.36×
0.95×
Q1 25
1.64×
Q4 24
5.51×
Q3 24
8.04×
1.42×
Q2 24
1.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MED
MED

Segment breakdown not available.

NBHC
NBHC

Net Interest Income$108.8M86%
Noninterest Income$18.0M14%

Related Comparisons